Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., April 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an...

Related Keywords

United Kingdom ,China , ,Nasdaq ,Prnewswire Karyopharm Therapeutics Inc ,Karyopharm Therapeutics Inc ,Selective Inhibitor Of Nuclear Export ,Linkedin ,Stock Incentive Plan ,Nasdaq Listing Rule ,Selective Inhibitor ,Nuclear Export ,Karyopharm Therapeutics ,Markets ,